“๐๐ก๐ ๐ช๐ฎ๐๐ฌ๐ญ๐ข๐จ๐ง ๐ข๐ฌ ๐ง๐จ๐ญ ๐ฐ๐ก๐๐ญ ๐ฒ๐จ๐ฎ ๐ฅ๐จ๐จ๐ค ๐๐ญ, ๐๐ฎ๐ญ ๐ฐ๐ก๐๐ญ ๐ฒ๐จ๐ฎ ๐ฌ๐๐.” โ ๐๐๐ง๐ซ๐ฒ ๐๐๐ฏ๐ข๐ ๐๐ก๐จ๐ซ๐๐๐ฎ For decades, Alzheimer’s research has looked at the same data: amyloid plaques, tau tangles, neuroinflammation. But what if we have been seeing it wrong? Two underappreciated forcesโchronic stress and an oral bacterium called P. gingivalisโmay be converging on the […]
Archive for the ‘Pharma and Medical Device’ Category
“๐๐ก๐ ๐ช๐ฎ๐๐ฌ๐ญ๐ข๐จ๐ง ๐ข๐ฌ ๐ง๐จ๐ญ ๐ฐ๐ก๐๐ญ ๐ฒ๐จ๐ฎ ๐ฅ๐จ๐จ๐ค ๐๐ญ, ๐๐ฎ๐ญ ๐ฐ๐ก๐๐ญ ๐ฒ๐จ๐ฎ ๐ฌ๐๐.” โ ๐๐๐ง๐ซ๐ฒ ๐๐๐ฏ๐ข๐ ๐๐ก๐จ๐ซ๐๐๐ฎ
Posted by Michael A. S. Guth on July 28th, 2026
๐๐ก๐ ๐ข๐ง๐ญ๐ซ๐๐๐๐ฅ๐ฅ๐ฎ๐ฅ๐๐ซ ๐ฅ๐จ๐๐ค๐๐จ๐ฑ: ๐ก๐ฒ๐ฉ๐๐ซ๐ฉ๐ก๐จ๐ฌ๐ฉ๐ก๐จ๐ซ๐ฒ๐ฅ๐๐ญ๐๐ ๐ญ๐๐ฎ: ๐จ๐ง๐ ๐๐ฌ๐ฉ๐๐๐ญ ๐จ๐ ๐ญ๐ก๐ ๐๐ฎ๐๐ฅ ๐๐๐ช๐ฎ๐๐ฌ๐ญ๐ซ๐๐ญ๐ข๐จ๐ง ๐๐ฒ๐ฉ๐จ๐ญ๐ก๐๐ฌ๐ข๐ฌ ๐๐ฒ ๐๐ข๐๐ก๐๐๐ฅ ๐. ๐. ๐๐ฎ๐ญ๐ก
Posted by Michael A. S. Guth on July 27th, 2026
While Aฮฒ patrols the extracellular space, the microtubule-associated protein tau functions within neurons. In its normal state, tau stabilizes micro-tubules, which are crucial for axonal transport and structural integrity. Its pathological transformation into hyperphosphorylated, aggregated NFTs is another diagnostic hallmark of AD and strongly correlates with cognitive decline (Jellinger, 2020). The DSH suggests viewing pathological […]
Has the definition of “positive neuroplasticity”ย and “negative neuroplasticity” evolved over time?
Posted by Michael A. S. Guth on July 23rd, 2026
Has the definition of “positive neuroplasticity”ย and “negative neuroplasticity” evolved over time? This publication,ย Vance DE, Roberson AJ, McGuinness TM, Fazeli PL. Howย neuroplasticity and cognitive reserve protect cognitive functioning. Jย Psychosoc Nurs Ment Health Serv. 2010 Apr;48(4):23-30. doi:ย 10.3928/02793695-20100302-01. PMID: 20349891,ย defined โPositive neuroplasticity refers to he physiologicalย ability of the brain to form and strengthen dendritic connections, produceย beneficial morphological changes, […]
๐๐ฎ๐๐ฅ ๐๐๐ช๐ฎ๐๐ฌ๐ญ๐ซ๐๐ญ๐ข๐จ๐ง ๐๐ฒ๐ฉ๐จ๐ญ๐ก๐๐ฌ๐ข๐ฌ ๐๐จ๐ซ ๐๐ฅ๐ณ๐ก๐๐ข๐ฆ๐๐ซ’๐ฌ ๐๐ข๐ฌ๐๐๐ฌ๐: ๐๐ก๐ ๐๐ฑ๐ญ๐ซ๐๐๐๐ฅ๐ฅ๐ฎ๐ฅ๐๐ซ ๐ฌ๐๐ซ๐๐จ๐ฉ๐ก๐๐ ๐ฎ๐ฌ: ๐๐ฆ๐ฒ๐ฅ๐จ๐ข๐-ฮฒย
Posted by Michael A. S. Guth on July 20th, 2026
๐๐ง ๐จ๐ฎ๐ซ ๐๐ฎ๐๐ฅ ๐๐๐ช๐ฎ๐๐ฌ๐ญ๐ซ๐๐ญ๐ข๐จ๐ง ๐๐ฒ๐ฉ๐จ๐ญ๐ก๐๐ฌ๐ข๐ฌ ๐๐จ๐ซ ๐๐ฅ๐ณ๐ก๐๐ข๐ฆ๐๐ซ’๐ฌ ๐๐ข๐ฌ๐๐๐ฌ๐: ๐๐ก๐ ๐๐ฑ๐ญ๐ซ๐๐๐๐ฅ๐ฅ๐ฎ๐ฅ๐๐ซ ๐ฌ๐๐ซ๐๐จ๐ฉ๐ก๐๐ ๐ฎ๐ฌ: ๐๐ฆ๐ฒ๐ฅ๐จ๐ข๐-ฮฒย We suggest reframing the Aฮฒ plaque not as a pathogenic endpoint but as an extracellular sarcophagusโa first-responder mechanism that sequesters insoluble or toxic material in the interstitial space. This view is supported by substantial evidence challenging Aฮฒ’s role as merely metabolic waste. From […]
Do the Biogen Diranersen Phase 2 (Celia study) results provide counter-evidence to my Dual Sequestration Hypothesis?
Posted by Michael A. S. Guth on July 14th, 2026
DSH vs. Biogen Diranersen Phase 2 (Celia study) โ Compatibility Assessment Bottom line: The Celia results do not constitute counter-evidence to DSH. They’re compatible with its core claim about therapeutic ceilings, but nothing in the trial tests DSH’s actual falsifiable content (nanoplastic nucleation, glymphatic obstruction, NLRP3/pyroptosis, NP-tangle colocalization). Log this as consistent-with, not confirmatory-of. 1. […]
Posted in Neuroplasticity, Pharma and Medical Device, Regulatory Medical Writing 
Comments Off on Do the Biogen Diranersen Phase 2 (Celia study) results provide counter-evidence to my Dual Sequestration Hypothesis?The Minority View of Aฮฒ in Alzheimer’s Disease is gaining ground on the Established View
Posted by Michael A. S. Guth on July 9th, 2026
We propose the DSH as a unifying framework to resolve these converging crises. This clinicopathological update posits that sporadic AD, particularly in its modern manifestation, could be understood as a disease of maladaptive innate immunity. The DSH suggests reframing Aฮฒ and tau pathologies not as intrinsic pathogens but as visible remnants of overwhelmed, evolutionarily conserved […]
Posted in Aging Adults, Neuroplasticity, Pharma and Medical Device, Regulatory Medical Writing Comments Off on The Minority View of Aฮฒ in Alzheimer’s Disease is gaining ground on the Established ViewThe Dual Sequestration Hypothesis as a Clinicopathological Synthesis
Posted by Michael A. S. Guth on July 6th, 2026
The Dual Sequestration Hypothesis as a Clinicopathological Synthesis We propose theย DSH as a unifying framework to resolve these converging crises. This clinicopathological update posits that sporadic Alzheimer’s disease, particularly in its modern manifestation, could be understood as a disease of maladaptive innate immunity. The DSH suggests reframing Aฮฒ and tau pathologies not as intrinsic pathogens […]
Posted in Aging Adults, Pharma and Medical Device, Regulatory Medical Writing Comments Off on The Dual Sequestration Hypothesis as a Clinicopathological Synthesis๐๐ก๐ ๐๐ข๐๐ซ๐จ๐ฉ๐ฅ๐๐ฌ๐ญ๐ข๐ ๐๐ก๐ซ๐๐๐ญ ๐๐๐๐๐ฅ๐๐ซ๐๐ญ๐ข๐ง๐ ๐๐ฅ๐ณ๐ก๐๐ข๐ฆ๐๐ซ’๐ฌ ๐๐ข๐ฌ๐๐๐ฌ๐
Posted by Michael A. S. Guth on July 6th, 2026
๐๐ก๐ ๐๐ข๐๐ซ๐จ๐ฉ๐ฅ๐๐ฌ๐ญ๐ข๐ ๐๐ก๐ซ๐๐๐ญ ๐๐๐๐๐ฅ๐๐ซ๐๐ญ๐ข๐ง๐ ๐๐ฅ๐ณ๐ก๐๐ข๐ฆ๐๐ซ’๐ฌ ๐๐ข๐ฌ๐๐๐ฌ๐ Parallel to this clinical quandary, environmental science has uncovered a novel, pervasive threat to neural integrity. Micro- and nanoplastics, ubiquitous contaminants of the Anthropocene, have infiltrated global ecosystems and, consequently, the human body. These synthetic polymer particles have been confirmed to breach critical biological barriers and have been detected […]
Posted in Aging Adults, Pharma and Medical Device, Regulatory Medical Writing Comments Off on ๐๐ก๐ ๐๐ข๐๐ซ๐จ๐ฉ๐ฅ๐๐ฌ๐ญ๐ข๐ ๐๐ก๐ซ๐๐๐ญ ๐๐๐๐๐ฅ๐๐ซ๐๐ญ๐ข๐ง๐ ๐๐ฅ๐ณ๐ก๐๐ข๐ฆ๐๐ซ’๐ฌ ๐๐ข๐ฌ๐๐๐ฌ๐The Hidden Gatekeeper: A Serial Killer Inside the Human Brain
Posted by Michael A. S. Guth on June 29th, 2026
The Hidden Gatekeeperย Best for an engaging, true-crime-style narrative that builds suspense paragraph by paragraph. For over thirty years, neurologists have been tracking a serial killer inside the human brain. We call its wake Alzheimerโs disease. When scientists look at the brains of those affected, they always find the same gruesome crime scene: millions of vital […]
Posted in Neuroplasticity, Pharma and Medical Device Comments Off on The Hidden Gatekeeper: A Serial Killer Inside the Human BrainThe choroid plexus (ChP): hydrodynamic bottleneck and ground zero for Alzheimer’s
Posted by Michael A. S. Guth on June 29th, 2026
The choroid plexus (ChP): hydrodynamic bottleneck and ground zero for Alzheimer’s diseaseย https://ejournals.uni-muenster.de/fnp/article/view/9368/9664 The Institute has advanced a Dual Sequestration Hypothesis (DSH) related to the protein signatures prevalent in Alzheimer’s disease.ย If the DSH is correct, the ChP should enlarge and become the sentinel hydrodynamic bottleneck as synthetic particles and their protein sequestrants accumulate. This […]
Posted in Featured, Neuroplasticity, Pharma and Medical Device Comments Off on The choroid plexus (ChP): hydrodynamic bottleneck and ground zero for Alzheimer’s